🇺🇸 FDA
Patent

US 6699842

Dominant negative deletion mutants of C-jun and their use in the prevention and treatment of cancer

expired A61KA61K31/711

Quick answer

US patent 6699842 (Dominant negative deletion mutants of C-jun and their use in the prevention and treatment of cancer) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/711